DCF — JACKSON PURCHASE MEDICAL CENTER
Enterprise Value: $-103.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-103.0M
Enterprise Value
$-33.6M
PV of Cash Flows
$-69.4M
PV of Terminal Value
$-111.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $93.9M | $-5.9M | -6.0% | $-9.8M | $-9.0M |
| Year 2 | $96.7M | $-5.1M | -5.0% | $-9.2M | $-7.6M |
| Year 3 | $99.6M | $-4.2M | -4.0% | $-8.5M | $-6.4M |
| Year 4 | $102.6M | $-3.9M | -4.0% | $-8.2M | $-5.6M |
| Year 5 | $105.7M | $-3.7M | -4.0% | $-8.2M | $-5.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-103.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$91.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.06757655761909417
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5